Genomic Valley Biotech share price update: Oct 2026

Stock in focus: BSE-only listing

Genomic Valley Biotech Ltd (BSE: 539206) traded lower in the Oct 19, 2026 session, with multiple intraday snapshots showing a decline from the previous close. The company is not listed on NSE, and several screens explicitly flagged “no data available” for NSE live volume and price fields. The stock sits within the broader Pharmaceuticals & Biotechnology universe on some trackers, while it is also tagged under Biotechnology & Medical Research and, elsewhere, under Miscellaneous. The mixed tagging is worth noting because it can affect how the stock appears in screeners and sector-based filters.

Oct 19 price action: from ₹34 to ₹32.59

BSE live data around 12:16 and 14:16 showed the share price at ₹34.00, down ₹0.30 (-0.87%), with a previous close of ₹34.30 and an open price of ₹34.00. By 15:32, the price was shown at ₹32.59, down ₹1.71 (-4.99%), indicating a sharper move later in the session. At that time stamp, bid and offer quantities were shown as 0.00 (0), suggesting limited visible depth on that snapshot. These readings, taken together, point to a weak close compared with the early-session level.

Listing details available to investors

The listing information provided for Genomic Valley Biotech includes a face value of ₹10 per equity share and a market lot of 1 share. The company is listed on BSE Ltd. Its ISIN is INE574D01010, and the BSE code is 539206. These identifiers are typically used by brokers, depositories, and corporate action systems to map the security correctly.

Company background and stated business lines

Genomic Valley Biotech Limited was incorporated in May 1994, with an objective to conduct research in biotechnology (plant and animal) and undertake commercial production of plant tissue cultured plants. The stated goal was to serve the genetically improved plant market in India and internationally. Another company profile described it as a development-stage company engaged in floriculture, including leasing ready-made greenhouses for farmers. The same profile also referenced research areas including agriculture, stem cell, food biotechnology, and environmental biotech product and process development. The company was founded on May 16, 1994 and is headquartered in Jhajjar, India.

Address and location details

The address provided for the company is: 4KM Stone, Berry Charra Road, Village Kher, Tehsil Bahadurgarh. It is located in Jhajjar District, Haryana, with PIN code 124507. Another line referenced “Company info: New Delhi,” indicating that some databases may show a different city field for correspondence or registration. Investors typically reconcile such differences by checking filings and the latest exchange disclosures.

Market cap, shareholding, and 52-week range

As of Oct 18, 2026, Genomic Valley Biotech’s market capitalization was stated at about ₹10.48 crore, and another snapshot cited ₹10.5 crore in the Pharmaceuticals & Biotechnology sector classification. Shareholding data as of Oct 18, 2026 showed promoters holding 46.1% and public shareholding at 53.9%. A 52-week high and low were provided as ₹38.2 and ₹20.1, respectively. These figures help frame the Oct 19 move in the context of the stock’s recent trading band.

Trading volume and a zero-price snapshot

A data point dated 16-10-2026 04:08 stated that the share price “today is ₹0,” with a change of ₹-34.30 (-100.00%) from a previous close of ₹34.3. The same entry also mentioned that the stock opened at ₹34.3, traded between ₹34.3 and ₹34.3, and recorded a total traded volume of 737 shares, alongside a market cap figure. Separately, a pre-opening snapshot displayed ₹34.30 with 0.00 (0.00%). The coexistence of these readings indicates that investors should cross-check price feeds on the exchange page or broker terminal when encountering inconsistent snapshots.

Order book clues: BSE market depth (Oct 16, 2026)

A BSE market depth table dated Oct 16, 2026 showed buy interest at ₹33.95 for 11 shares, while sell-side quantities were visible at ₹34.25 (249 shares), ₹34.30 (383 shares), and ₹35.95 (400 shares). Such depth snapshots are time-specific, but they can still help explain why prices may struggle to move higher when sell quantities sit close to the traded price. The same screen also displayed a “Bid/Ask 0.00 / 0.00” line elsewhere, again highlighting that different widgets can show different states.

Market impact: what the numbers indicate

For a small-cap stock with limited reported depth and occasional “no data” fields on NSE screens due to non-listing, liquidity and data quality matter as much as price. The movement from ₹34.00 to ₹32.59 within the same trading day, along with bid-offer fields sometimes showing zero, suggests that execution prices can vary meaningfully depending on available orders at a given moment. Investors tracking the stock should rely on the BSE listing and confirm intraday moves via official exchange data when possible. The 0% dividend yield statement and the market lot size of 1 share indicate accessibility for small orders, but price discovery can still be uneven when volumes are thin.

Analysis: classification, visibility, and due diligence

Genomic Valley Biotech appears under multiple sector labels across sources, including Biotechnology & Medical Research, Healthcare, and Miscellaneous, with at least one reference to an Agriculture sector tag. This matters for passive discovery because many investors screen by sector and industry. The company’s described activities spanning tissue culture, floriculture, greenhouse leasing, and multiple biotech research areas can contribute to inconsistent categorisation across databases. With promoters holding 46.1% and public holding 53.9% (as of Oct 18, 2026), daily liquidity can be sensitive to changing participation by public shareholders.

Conclusion

Genomic Valley Biotech’s BSE share price weakened on Oct 19, 2026, ending a later snapshot at ₹32.59 after trading near ₹34.00 earlier, against a previous close of ₹34.30. Key identifiers such as BSE code 539206 and ISIN INE574D01010 confirm the security, while the company remains unlisted on NSE. With market cap around ₹10.5 crore and a 52-week range of ₹20.1 to ₹38.2, investors typically monitor exchange-verified prices and liquidity signals closely. Any further clarity on trading data consistency would depend on subsequent official exchange updates and broker feed reconciliation.